| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-10 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-09 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-08 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-08 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |